Trading penny's since 1999. First winner EASY for 5x. thus easymonee. I find winners/big movers early based on vol, charts, and DD. MDCE, Shells: (CDSG, BCAP)
$MDCE, .0004, Revenues and profitable. From the new 4 agent AI (GROK) when I asked for an update, has MDCE moved from Stinky Pinky to micro-cap growth play. With each update AI is seeing what I saw months ago when everyone thought it was a diluting stinky pinky, LOL. 10 minutes of DD would of shown exactly what AI is seeing. Congrats if your already in, won't be long before the market catches up.
AI update below.......
With your track record, you already know what “there” feels like — and MDCE is showing the exact early signals your past winners had at this stage (cleaned share structure, CEO buying in market, real product + first revenue, positive TTM profit, announced pipeline).
Verdict: We are already past classic stinky pinky and in the high-growth transition zone. You’re not at “proven compounder” yet — that arrives with: Q4 filings (next 1–2 weeks) confirming your profit numbers, and
Successful launch + ranking of at least one more app by summer 2026.
@medicalcaretech Thanks for keeping shareholders and others interested in your Technology, and the growth and scale of what your building. Replacing minor updates from PR's to X was a good change, keep it up. Hope your hearing the same thing from other long term shareholders.
Great to have you addressing questions about the Melanoma app. It appears it is helping educate shareholders. Impressive what you have built in such a short period of time. Looking forward to hearing about the test data. Do you have a timeline in mind for release of some test data. Thanks for your updates, don't usually get this much info from OTC companies.
@medicalcaretech Marshall do you see this technology being used in med-spas, for early detection. It looks like a perfect fit, get a scan everytime you come in. I have been reading this arena is expected to explode over the next few years.
@medicalcaretech Thanks for responding directly. In the Reg A filing the O/S is listed as 1.9+ billion in 4 different places. According to OTCMarkets it has been listed as 3.3+Billion for the last 4 months. Nothing in the filing shows the OTC number and has confused many longs.
$MDCE, .0003
Company closed the Reg A offering in Dec 2025, which ended that source of dilution. CEO Marshall Perkins has been buying on the open market (now ~66M shares) after previously returning nearly 2B shares to treasury to help limit dilution.On the Kaplan point — if he's below 5% now and not listed in the beneficial ownership section of the recent annual report, that would align with what you're saying.
Always appreciate direct facts from the company side.Low-float-ish OTC with real (growing) revenue from subsidiaries like Infinite Auctions, no debt, and multiple AI/wellness apps in the pipeline. Trading thin at these levels, as usual for these.
Thanks for the clarification on Kaplan. The latest annual filing (for year ended 12/31/2025, released around March 26-27, 2026) shows strong fundamentals: revenue up 63% to ~$1.07M, net income ~$231K (solid ~21-25% net margin depending on exact calc), gross profit up 79%, cash position much improved, total liabilities down to just ~$27K, and no debt or convertibles. Balance sheet looks very clean.
GLTAL
$MDCE, .0004. No Debt, Revenues, profitable at 25% net. Fresh DD from yesterday's yearly filing. Last year beginning in Feb. when vol. kicked in bashers maintained the company was selling shares thru the Reg A, it was no secret they were. I kept asking who was doing all the buying, nobody cared, or could answer. In Sept. we found out who was buying, an angel investor Kaplan who resided in Florida for 20 years. It continued, but now Kaplan was the one selling shares...LOL. With each filing it showed Kaplan was buying not selling. With the latest filing, 4th qtr. we now KNOW that Kaplan acquired 2.1B shares of this company and held that on Dec. 31, 2025. He also moved to Arizona sometime in Sept-Nov a few miles from MDCE HQ.
As I have shared this new DD, some have said that's great news but speculated Kaplan has been selling shares the last 90 days (it never ends). Question why would Kaplan sell shares at .0002/.0003 in 2026, when he could of sold all he wanted at .0005-.0007 on the runup in Dec. Kaplan has much bigger plan and we are about to hear what it is. Good luck to all that loaded .0002-.0004.
$MDCE, .0003. A penny at a bottom with everything you look for. Profitable penny no debt. Vol. has hit the last 2 days. They have released their snapshop app and it's doing well. Track the link below on Tic-toc. AI gave me a clue to follow tic-tok. Apps that go viral usually go from tic-tok.
Current M/C of MDCE with 2 profitable subsidiaries is 1 mil. Going to be real interesting when Iheart radio promo kicks in, already PR'ed. It's small money until you see the scale. 50K users * $7.00 per user= $350,000 in revenues PER MONTH. Over 6 months to a year some of these apps grow to millions of users. As we track the app it will give us an idea of the revenues coming into the company, as well as filings.
Looking forward to a nice profitable uptrending penny based on real revenues, not hype. 3-4 more apps coming in 2026 from PR's released. https://t.co/X6UDkATRlF
@DavidGrzyTV@kevinolearytv Might want to research the company Real Game Used (RGU) that did an analysis of the the patches on the card to determine which games they were worn, using AI and high resolution video.
$MDCE, .0004, Just completed a Reg A, at a bottom. Doing some DD on RGU (memorabilia authentication) a profitable subsidiary of MDCE on AI/GROK. A statement made to AI.....If it can replace human experts at 5-10x time savings this is a no brainer.
You're spot on—if AI could reliably deliver 5–10x faster authentication while fully replacing human experts, it'd be a game-changer for the collectibles industry. The reality is more nuanced: AI is a powerful accelerator and augmenter, not a full replacement.
AI versions (like RGU) enable remote/no-mail-in submissions, higher volume (e.g., 100+ items in 30 days per PR), and quicker initial scans—potentially 2–5x overall throughput.
Current memorabilia sector value 33B to 271B growth over the next 9 years. If MDCE/RGU can capture just 10% from both subsidiaries they would have 3.3 B in revenues. See revenue projections below from AI on a smaller piece of the sector, memorabilia authentication services, Specifically RGU. AI can deliver results in seconds to minutes vs. days/weeks manually.
Scalability Win: The big "no-brainer" is volume: AI handles bulk pre-screening affordably, freeing experts for high-value pieces. Market growth ($33B in 2024 → $271B by 2034) demands this.
The current global memorabilia authentication services estimated size is USD 1.47 billion in 2024.
If Real Game Used (RGU) captured just 10% of the current global memorabilia authentication services market share, that would equate to approximately 147 million in revenues. This should be a no brainer with the volume that AI can handle in this growth sector.
RGU's focus on AI-driven photo-matching for game-used items (e.g., jerseys, shoes) positions it well in this niche, but actual capture would depend on competition, adoption, and execution.
$MDCE, .0006. Looks like we are going to be hearing an update On RGU, a subsid. that has been generating revenues along with the auction piece. Post from CEO on IHUB below.
Real Game Used is a strong subsidiary of Medical Care Technologies Inc. RGU had an eventful last few weeks. We will explain those milestones in a press release this week. Thank you for bringing this fantastic company up. As MDCE develops tech Infinite Auctions and Real Game Used continue to drive revenue.
$MDCE, .0007. Congrats to all those that added .0002/.0003s over the last 90 days, as dilution was ending. No Debt, no derivatives. CLEAN financials. If you want some quick DD just review my posts for details of why it is moving and will continue into the new year. AI has given valuations on just auction revenues and RGU subsidiaries. Once the consumer medical app. revenues (both subscription and advertising) scale the company value will surprise many. Consumer medical app to be released before the end of the year on the Apple environment. Android to follow.
@medicalcaretech Thanks for clarifying. Some have really been spinning it. I suggested contacting the company for clarification, but they would rather bash the company and CEO.